Monday, February 10, 2020

Marksans Pharma gets EIR from USFDA for New York unit

Marksans Pharma gets EIR from USFDA for New York unit In a regulatory filing, the company announced "receipt of the EIR from US Food and Drug Administration (USFDA) in respect of inspection of company#39;s manufacturing facility Time-Cap Laboratories Inc. located at Farmingdale, New York, USA carried out from December 5, 2019 to December 18, 2019".

from Moneycontrol Business News https://ift.tt/2Hdx2sI
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bitcoin stays near $64K, Ethereum underperforms as weak risk appetite keeps crypto markets under pressure

Bitcoin traded near $64,000 and Ethereum underperformed as risk appetite weakened. The global crypto market capitalization edged down 2% to ...